Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Symonds

Showing results (11-20 of 70) with videos related to

Pageof 7
Sort By:
Clinical Pharmacokinetics|March 31, 2015
Pharmacokinetic, Pharmacodynamic, and Drug-Interaction Profile of the Hepatitis C Virus NS5B Polymerase Inhibitor SofosbuvirBrian J Kirby, William T Symonds, Brian P Kearney, et al.
Antimicrobial Agents and Chemotherapy|December 25, 2012
Pharmacokinetics, safety, and tolerability of GS-9851, a nucleotide analog polymerase inhibitor for hepatitis C virus, following single ascending doses in healthy subjectsJill Denning, Melanie Cornpropst, Stephen D Flach, et al.
Journal of Wound Care|March 3, 2005
Measuring the impact of venous leg ulcers on quality of lifeA Hareendran, A Bradbury, J Budd, et al.
Spinal Cord|August 25, 2010
Sildenafil in women with sexual arousal disorder following spinal cord injuryM S Alexander, R C Rosen, S Steinberg, et al.
BMC Musculoskeletal Disorders|May 18, 2017
Multidimensional daily diary of fatigue-fibromyalgia-17 items (MDF-fibro-17). part 1: development and content validityS Morris, Y Li, J A M Smith, et al.
ACS Applied Materials & Interfaces|January 10, 2026
High-Throughput Screening of Experimental Metal-organic Frameworks for High Water Content Syngas Hydrogen Purification under Pressure Swing Adsorption ConditionsJun Luo, Marco Gibaldi, Samira Rostom, et al.
Antimicrobial Agents and Chemotherapy|December 24, 2004
Single-dose safety and pharmacokinetics of amprenavir (141W94), a human immunodeficiency virus type 1 (HIV-1) protease inhibitor, in HIV-infected childrenRam Yogev, Andrea Kovacs, Ellen G Chadwick, et al.
Science (New York, N.Y.)|February 4, 2006
Fish population and behavior revealed by instantaneous continental shelf-scale imagingNicholas C Makris, Purnima Ratilal, Deanelle T Symonds, et al.
Antimicrobial Agents and Chemotherapy|July 2, 1999
Safety and pharmacokinetics of amprenavir (141W94), a human immunodeficiency virus (HIV) type 1 protease inhibitor, following oral administration of single doses to HIV-infected adultsB M Sadler, C D Hanson, G E Chittick, et al.
International Journal of Impotence Research|November 21, 2008
Turkish validation of the premature ejaculation diagnostic tool and its association with intravaginal ejaculatory latency timeE C Serefoglu, H I Cimen, A T Ozdemir, et al.
Pageof 7

Showing results (11-20 of 70) with videos related to

Sort By:
Pageof 7
Clinical Pharmacokinetics|March 31, 2015
Pharmacokinetic, Pharmacodynamic, and Drug-Interaction Profile of the Hepatitis C Virus NS5B Polymerase Inhibitor SofosbuvirBrian J Kirby, William T Symonds, Brian P Kearney, et al.
Antimicrobial Agents and Chemotherapy|December 25, 2012
Pharmacokinetics, safety, and tolerability of GS-9851, a nucleotide analog polymerase inhibitor for hepatitis C virus, following single ascending doses in healthy subjectsJill Denning, Melanie Cornpropst, Stephen D Flach, et al.
Journal of Wound Care|March 3, 2005
Measuring the impact of venous leg ulcers on quality of lifeA Hareendran, A Bradbury, J Budd, et al.
Spinal Cord|August 25, 2010
Sildenafil in women with sexual arousal disorder following spinal cord injuryM S Alexander, R C Rosen, S Steinberg, et al.
BMC Musculoskeletal Disorders|May 18, 2017
Multidimensional daily diary of fatigue-fibromyalgia-17 items (MDF-fibro-17). part 1: development and content validityS Morris, Y Li, J A M Smith, et al.
ACS Applied Materials & Interfaces|January 10, 2026
High-Throughput Screening of Experimental Metal-organic Frameworks for High Water Content Syngas Hydrogen Purification under Pressure Swing Adsorption ConditionsJun Luo, Marco Gibaldi, Samira Rostom, et al.
Antimicrobial Agents and Chemotherapy|December 24, 2004
Single-dose safety and pharmacokinetics of amprenavir (141W94), a human immunodeficiency virus type 1 (HIV-1) protease inhibitor, in HIV-infected childrenRam Yogev, Andrea Kovacs, Ellen G Chadwick, et al.
Science (New York, N.Y.)|February 4, 2006
Fish population and behavior revealed by instantaneous continental shelf-scale imagingNicholas C Makris, Purnima Ratilal, Deanelle T Symonds, et al.
Antimicrobial Agents and Chemotherapy|July 2, 1999
Safety and pharmacokinetics of amprenavir (141W94), a human immunodeficiency virus (HIV) type 1 protease inhibitor, following oral administration of single doses to HIV-infected adultsB M Sadler, C D Hanson, G E Chittick, et al.
International Journal of Impotence Research|November 21, 2008
Turkish validation of the premature ejaculation diagnostic tool and its association with intravaginal ejaculatory latency timeE C Serefoglu, H I Cimen, A T Ozdemir, et al.
Pageof 7